AUSTRALIAN Securities Exchange (ASX) listed digital medication management business MedAdvisor has clarified its joint venture (JV) with Klinify (PD 13 Sep).
In a statement to the ASX, MedAdvisor said the initial term of the agreement was for one year, with further automatic extensions of one year unless notice of termination is received.
The agreement provides for a three-month written notice period for termination without cause, and immediate termination upon bankruptcy or unrectified breach 60-days after notice.
The JV aims to boost medication adherence of two million Malaysian patients.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Sep 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Sep 19